1. Home
  2. SON vs LQDA Comparison

SON vs LQDA Comparison

Compare SON & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

N/A

Current Price

$59.37

Market Cap

5.6B

ML Signal

N/A

LQDA

Liquidia Corporation

N/A

Current Price

$68.79

Market Cap

5.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SON
LQDA
Founded
1899
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.5B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SON
LQDA
Price
$59.37
$68.79
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$60.13
$41.00
AVG Volume (30 Days)
1.0M
1.6M
Earning Date
04-21-2026
05-08-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
51.81
EPS
0.68
1.26
Revenue
$7,518,753,000.00
$158,320,000.00
Revenue This Year
$0.10
$278.87
Revenue Next Year
$1.82
$57.13
P/E Ratio
$85.78
$56.39
Revenue Growth
41.72
1031.18
52 Week Low
$38.65
$21.15
52 Week High
$60.67
$93.61

Technical Indicators

Market Signals
Indicator
SON
LQDA
Relative Strength Index (RSI) 60.66 35.96
Support Level $46.53 $31.99
Resistance Level $60.67 $92.35
Average True Range (ATR) 1.26 4.75
MACD -0.07 -2.21
Stochastic Oscillator 94.05 2.84

Price Performance

Historical Comparison
SON
LQDA

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: